Replies to post #192117 on Biotech Values

[DewDiligence]

ENDP -17% on new slide deck for Barclays webcast:

http://www.sec.gov/Archives/edgar/data/1593034/000119312516507445/d160707dex991.htm

“Roll-up” business similarities to VRX are probably part of the reason for the selloff.